化工社化工社 化学情報印刷レポート · 研究参考用
Citric Acid → Trisodium citrate
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Citric Acid | HCID 311 | — |
| 反応物 | Water | HCID 962 | — |
| 反応物 | Potassium Carbonate | HCID 11430 | — |
| 反応物 | Duloxetine | HCID 60835 | — |
| 反応物 | Sodium Bicarbonate | HCID 516892 | — |
| 生成物 | Trisodium citrate | HCID 6224 | — |
| 生成物 | Tripotassium citrate | HCID 13344 | — |
| 生成物 | Duloxetine | HCID 60835 | — |
反応手順
Effervescent Tablets and Granules were prepared using standards techniques known to persons skilled in the art. For Example: From one 20 mg duloxetine capsule, granules were emptied into mortar and pestle to prepare fine powder. A homogeneous mixture of effervescent duloxetine powder was obtained by diluting the above powdered duloxetine with about 958 mg sodium bicarbonate USP, about 832 mg citric acid USP and about 312 mg potassium carbonate USP. This powder reacted with the 60 ml water to create effervescence resulting in a bubbling solution of duloxetine with sodium citrate and potassium citrate as principal antacids
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US08093408B2 |
| 出典データセット | uspto-grants-2012_01 |
| ORD ID | ord-3fe1b42f4dd541bba16678b948a2ee70 |
| 出典メモ | uspto-grants-2012_01 |